AVTX logo

Avalo Therapeutics, Inc. Common Stock


AVTX: Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006.


Show AVTX Financials

Consumer Interest
SEC Filings

Recent trades of AVTX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by AVTX's directors and management

Government lobbying spending instances

  • $30,000 Apr 19, 2023 Issue: Medical/Disease Research/Clinical Labs
  • $30,000 Jan 18, 2023 Issue: Medical/Disease Research/Clinical Labs
  • $30,000 Oct 19, 2022 Issue: Medical/Disease Research/Clinical Labs
  • $30,000 Jul 18, 2022 Issue: Medical/Disease Research/Clinical Labs
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of AVTX in WallStreetBets Daily Discussion


Recent insights relating to AVTX

CNBC Recommendations

Recent picks made for AVTX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in AVTX

Corporate Flights

Flights by private jets registered to AVTX